David Proudman

David Proudman is a seasoned professional with extensive experience in health economics, data science, and investment research. Since February 2019, David has served as a Manager at Analysis Group, specializing in health economic modeling, biostatistics, and Health Technology Assessment consulting. Prior to this role, David worked as a Data Scientist at UCSF Medical Center, focusing on statistics research, and as a Summer Associate at NICE, where David contributed to evidence synthesis for a cardiac procedure and coordinated an EU project for Health Technology Assessment standards. David also held significant positions at Highclere International Investors as Director of Research and Lead Analyst, and at ABN AMRO Bank N.V. as an Analyst. David's educational background includes a Master of Public Health from the University of California, Berkeley, and an MBiochem in Molecular and Cellular Biochemistry from the University of Oxford, graduating in the top 3%.